| scholarly article | Q13442814 |
| P2093 | author name string | Jun-Jie Liu | |
| Yuan-Yuan Chen | |||
| Zhi-Xian Li | |||
| Yong Gao | |||
| Hai-Ying Zhang | |||
| Xiao-Bo Yang | |||
| Zeng-Nan Mo | |||
| Ai-Hua Tan | |||
| Gui-Xiang Tian | |||
| P2860 | cites work | In vitro chronic hepatic disease characterization with a multiparametric ultrasonic approach. | Q51535346 |
| The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients | Q80178367 | ||
| How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? | Q80470863 | ||
| Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease | Q83386729 | ||
| Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey | Q83480169 | ||
| Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese | Q83647397 | ||
| Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration | Q84805836 | ||
| Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men | Q86029701 | ||
| Endocrine regulation of energy metabolism by the skeleton | Q22337453 | ||
| Nonalcoholic fatty liver disease | Q24555779 | ||
| Association between serum osteocalcin and markers of metabolic phenotype | Q24644655 | ||
| Treatment of non-alcoholic fatty liver disease | Q24655572 | ||
| What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? | Q30361645 | ||
| Epidemiology of non-alcoholic fatty liver disease in China. | Q30373353 | ||
| Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome | Q34129927 | ||
| New clinical score to diagnose nonalcoholic steatohepatitis in obese patients | Q34662500 | ||
| AGA technical review on nonalcoholic fatty liver disease | Q34982453 | ||
| Diagnosis of fatty liver disease: is biopsy necessary? | Q35110258 | ||
| Pathophysiology of nonalcoholic steatohepatitis | Q36422705 | ||
| Diagnostic evaluation of nonalcoholic fatty liver disease | Q36422714 | ||
| Review: The role of insulin resistance in nonalcoholic fatty liver disease | Q36591903 | ||
| The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | Q37061247 | ||
| The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism | Q37866694 | ||
| Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk. | Q38021479 | ||
| Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels | Q43054615 | ||
| Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss | Q43142226 | ||
| Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals | Q43293845 | ||
| The utility of radiological imaging in nonalcoholic fatty liver disease. | Q44116674 | ||
| Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism | Q45866158 | ||
| Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. | Q46124754 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| osteocalcin | Q59250722 | ||
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | 19782-19791 | |
| P577 | publication date | 2013-09-30 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China | |
| P478 | volume | 14 |
| Q89736258 | Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes |
| Q91650707 | First-degree family history of diabetes and its relationship with serum osteocalcin levels independent of liver fat content in a non-diabetic Chinese cohort |
| Q36751951 | Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels |
| Q37703491 | Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle |
| Q53624787 | Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. |
| Q33569709 | Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome |
| Q40043672 | Reduced serum IGF-1 associated with hepatic osteodystrophy is a main determinant of low cortical but not trabecular bone mass |
| Q34960581 | Relationships between the Osteocalcin gene polymorphisms, serum osteocalcin levels, and hepatitis B virus-related hepatocellular carcinoma in a Chinese population |
| Q36493129 | Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease |
Search more.